Search Results for: coronavirus
Skip to results
529 results
529 results for: coronavirus
-
These are the most popular Science News stories of 2022
Science News drew over 13 million visitors to our website this year. Here’s a recap of the most-read news stories and long reads of 2022.
- Health & Medicine
Merck’s COVID-19 pill may soon be here. How well will it work?
Once hailed as a potential game changer, more complete data now reveal drawbacks of Merck’s antiviral COVID-19 pill, molnupiravir.
- Health & Medicine
4 answers to key questions about the monkeypox outbreak
Monkeypox has cropped up around the world, but it doesn’t spread easily like the coronavirus and most people probably don’t need to be concerned.
- Health & Medicine
A new antiviral pill cuts COVID-19 hospitalization and death rates
Merck says its drug, molnupiravir, stops viral replication and can be taken right after a COVID-19 diagnosis.
- Health & Medicine
New studies hint that the coronavirus may be evolving to become more airborne
More coronavirus RNA is in fine aerosols than in larger droplets, but masks can reduce the amount of virus in the air.
-
The triumph and fallibility of science in a historic year
Editor in chief Nancy Shute discusses the last year in science, including lessons we've learned about COVID-19, human evolution and amazing animal feats.
- Health & Medicine
What experts told me to do after my positive COVID-19 at-home test
Rapid at-home tests mean many COVID-19 cases go unreported, but they’re a great tool for deciding when to leave isolation. I found that out firsthand.
- Health & Medicine
An anime convention in November was not an omicron superspreader event
Vaccines, ventilation and other safety measures probably prevented the variant’s spread at Anime NYC, reports suggest.
- Health & Medicine
In 2021, COVID-19 vaccines were put to the test. Here’s what we learned
Vaccines can’t single-handedly end the pandemic, but they are still essential in the fight against the coronavirus.
- Health & Medicine
The CDC recommends mRNA COVID-19 vaccines over J&J’s, citing fewer risks
Pfizer’s and Moderna's vaccines are more effective and cause fewer serious side effects than Johnson & Johnson’s jab, new data show.
- Health & Medicine
The first known monkeypox infection in a pet dog hints at spillover risk
A person passed monkeypox to a dog. Other animals might be next, allowing the virus to set up shop outside of Africa for the first time.
- Health & Medicine
Bird flu can jump to mammals. Should we worry?
Reports of bears and sea lions infected with H5N1 have sparked fears about the pandemic potential of bird flu. Experts are keeping a close eye on its spread.
